Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ovarian cancer drug trial tests DNA changes before surgery

NCT ID NCT02659241

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times

Summary

This early-phase trial is testing how the drug adavosertib affects the DNA of tumor cells in 38 people with advanced ovarian, fallopian tube, or peritoneal cancer before they have surgery. The goal is to learn how the drug changes the cancer's DNA, which may help doctors plan better treatments in the future. Participants take the drug for up to 28 days before surgery, and researchers compare their tumor samples before and after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE HIGH GRADE SEROUS ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

  • MD Anderson League City

    League City, Texas, 77573, United States

  • MD Anderson West Houston

    Houston, Texas, 77079, United States

  • MD Anderson in Sugar Land

    Sugar Land, Texas, 77478, United States

  • MD Anderson in The Woodlands

    Conroe, Texas, 77384, United States

  • Memorial Hermann Memorial City Medical Center

    Houston, Texas, 77024, United States

  • OHSU Knight Cancer Institute

    Portland, Oregon, 97239, United States

  • The Woman's Hospital of Texas

    Houston, Texas, 77054, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED FALLOPIAN TUBE CARCINOMA ADVANCED OVARIAN CARCINOMA ADVANCED PRIMARY PERITONEAL CARCINOMA CARCINOMATOSIS CARCINOMATOSIS FALLOPIAN TUBE HIGH GRADE SEROUS ADENOCARCINOMA OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA PRIMARY PERITONEAL HIGH GRADE SEROUS ADENOCARCINOMA STAGE III FALLOPIAN TUBE CANCER AJCC V7 STAGE III FALLOPIAN TUBE CANCER AJCC V7 STAGE III OVARIAN CANCER AJCC V6 AND V7 STAGE III OVARIAN CANCER AJCC V6 AND V7 STAGE III OVARIAN CANCER AJCC V6 AND V7 STAGE III PRIMARY PERITONEAL CANCER AJCC V7 STAGE III PRIMARY PERITONEAL CANCER AJCC V7 STAGE III PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIA FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIA FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIA FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIA OVARIAN CANCER AJCC V6 AND V7 STAGE IIIA OVARIAN CANCER AJCC V6 AND V7 STAGE IIIA OVARIAN CANCER AJCC V6 AND V7 STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIA PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIB FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIB OVARIAN CANCER AJCC V6 AND V7 STAGE IIIB OVARIAN CANCER AJCC V6 AND V7 STAGE IIIB OVARIAN CANCER AJCC V6 AND V7 STAGE IIIB PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIB PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIB PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIC FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIC FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIC FALLOPIAN TUBE CANCER AJCC V7 STAGE IIIC OVARIAN CANCER AJCC V6 AND V7 STAGE IIIC OVARIAN CANCER AJCC V6 AND V7 STAGE IIIC OVARIAN CANCER AJCC V6 AND V7 STAGE IIIC PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIC PRIMARY PERITONEAL CANCER AJCC V7 STAGE IIIC PRIMARY PERITONEAL CANCER AJCC V7 STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7 STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7 STAGE IV OVARIAN CANCER AJCC V6 AND V7 STAGE IV OVARIAN CANCER AJCC V6 AND V7 STAGE IV PRIMARY PERITONEAL CANCER AJCC V7 STAGE IV PRIMARY PERITONEAL CANCER AJCC V7